Press release
Global Blepharitis Market Production, Revenue, Price Trend & Forecast Report 2017-2022
Reports Monitor
Blepharitis - Pipeline Review, H2 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Blepharitis - Pipeline Review, H2 2017, provides an overview of the Blepharitis (Ophthalmology) pipeline landscape.
Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin, blockage of the eyelid's oil glands, and occasionally allergies. Blepharitis signs and symptoms include watery eyes, red eyes, itchy eyelids, sensitivity to light. Treatment includes antibiotics, lubricating eye drops and steroid eye drops or ointments.
Browse Full Table of Contents and Report Description @ https://www.reportsmonitor.com/blepharitis-pipeline-review-h2-2017/
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Blepharitis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Blepharitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Blepharitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Blepharitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 1, 1 and 5 respectively.
Blepharitis (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Blepharitis (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Blepharitis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Blepharitis (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Blepharitis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Blepharitis (Ophthalmology)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Blepharitis (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Blepharitis (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
For Requesting a Sample Copy of This Report, Please Visit @ https://goo.gl/bYs8Yj
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Blepharitis – Overview
Blepharitis – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Blepharitis – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Blepharitis – Companies Involved in Therapeutics Development
Hovione FarmaCiencia SA
InSite Vision Inc
Kala Pharmaceuticals Inc
Marinomed Biotechnologie GmbH
Merck & Co Inc
NicOx SA
Quorum Innovations LLC
Blepharitis – Drug Profiles
azithromycin – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dexamethasone acetate – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fluticasone propionate – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ISV-405 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
loteprednol etabonate – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Qi-402 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Blepharitis and Conjunctivitis – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
solithromycin – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tetracycline – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Blepharitis – Dormant Projects
Blepharitis – Product Development Milestones
Featured News & Press Releases
Jan 05, 2017: Nicox provides clinical and regulatory update for NCX 4251 in blepharitis
Jul 08, 2014: InSite Vision Plans to Submit New Drug Application to FDA for DexaSite for the Treatment of Blepharitis in Adults
Nov 12, 2013: Kala Pharmaceuticals Presents Preclinical Data on Mucus Penetrating Particles at 2013 AAPS Annual Meeting and Exposition
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
About Us
Reports Monitor (ReportsMonitor.com) is a platform to meet the market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. We have a vast collection of reports, covering maximum industries worldwide. Our process is meticulously planned and executed in order to use maximum resources and explore the market for getting genuine insights. Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.
Contact Us
Jay Matthews
Direct: +1 513 549-5911
Email: sales@reportsmonitor.com
Website: www.reportsmonitor.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Blepharitis Market Production, Revenue, Price Trend & Forecast Report 2017-2022 here
News-ID: 685866 • Views: …
More Releases from Reports Monitor
Civil Engineering Design Software Market Share, Growth, Overview, Trends, CAGR a …
Civil Engineering Design Software Market 2020
The Civil Engineering Design Software industry has also suffered a certain impact, but still maintained a relatively optimistic growth.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market…
Business Intelligence Platforms Software Market Share, Future Growth, CAGR and F …
Business Intelligence Platforms Software Market 2020
The Business Intelligence Platforms Software industry has also suffered a certain impact, but still maintained a relatively optimistic growth.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market…
Impact of Covid-19 on Brokerage Management Software Market - Current Scenario, K …
Brokerage Management Software Market 2020
The Brokerage Management Software industry has also suffered a certain impact, but still maintained a relatively optimistic growth.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume…
Impact of Covid-19 on Big Data Analytics Software Market 2020-2025, Keyplayers - …
Big Data Analytics Software Market 2020
The Big Data Analytics Software industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional…
More Releases for Blepharitis
Top Trends Transforming the Blepharitis Market Landscape in 2025: Targeted Anti- …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Blepharitis Industry Market Size Be by 2025?
The expansion of the blepharitis market has been exponential in the past few years. The market size is expected to surge from $0.86 billion in 2024 to $0.97 billion in 2025, with a compound annual growth rate (CAGR) of…
Blepharitis Drugs Market: An In-Depth Analysis
The global Blepharitis Drugs market was valued approximately $1.5 billion in 2023 and is projected to reach around $1.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.4% during the forecast period.
Blepharitis Drugs Market Overview
Blepharitis is an inflammatory condition of the eyelids, leading to symptoms such as redness, irritation, and crusting near the base of the eyelashes. The market's growth is driven by factors including…
Blepharitis Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Blepharitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Blepharitis, historical and forecasted epidemiology, and the Blepharitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
The Blepharitis market report provides current treatment practices, emerging drugs, the market share of individual therapies, and the current and forecasted Blepharitis market size from 2019 to 2032, segmented by seven…
Blepharitis Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Blepharitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Blepharitis Market, historical and forecasted epidemiology as well as the Blepharitis Market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Blepharitis Market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Blepharitis Market size from 2019 to 2032,…
Blepharitis Drugs Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Blepharitis Drugs Market Analysis and Forecast 2019-2024 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Blepharitis Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,…
Blepharitis Drugs Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Blepharitis Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Blepharitis Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Blepharitis Drugs with respect to individual growth…
